1-(Bromomethyl)-4-chlorobenzene(cas: 622-95-7) undergoes carbonylation in the presence of dimer of chloro(1,5-cyclooctadiene)rhodium(I) to yield the corresponding phenylacetic acid.Application In Synthesis of 1-(Bromomethyl)-4-chlorobenzene It can be synthesized by reacting 4-chlorobenzyl alcohol with bromodimethylsulfonium bromide (BDMS) It can also be synthesized by refluxing a mixture of 4-chlorobenzaldehyde, chlorotrimethylsilane, 1,1,3,3-tetramethyldisiloxane and lithium bromide.
Application In Synthesis of 1-(Bromomethyl)-4-chlorobenzeneIn 2019 ,《Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors》 appeared in Bioorganic Chemistry. The author of the article were Mo, Jun; Yang, Hongyu; Chen, Tingkai; Li, Qihang; Lin, Hongzhi; Feng, Feng; Liu, Wenyuan; Qu, Wei; Guo, Qinglong; Chi, Heng; Chen, Yao; Sun, Haopeng. The article conveys some information:
A series of quinoline-ferulic acid hybrids I (R = 1-chloro-4-(2-methoxyphenoxymethyl)benzene, 3-cyanophenyl, 4-(benzyloxy)-3-methoxyphenyl, etc.; R1 = H, Me; n = 1, 2, 3) has been designed, synthesized, and evaluated as cholinesterase inhibitors. Most of the compounds showed good inhibitory activities toward both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). Among them, I (R = 1-bromo-4-(2-methoxyphenoxymethyl)benzene; R1 = Me; n = 1 (A)) was found to be the most potent inhibitor against AChE (IC50 = 0.62 ± 0.17 μM), and I (R = phenyl; R1 = Me; n = 3) was the most potent inhibitor against BChE (IC50 = 0.10 ± 0.01 μM). Representative compounds, such as (A) and I (R = 4-(trifluoromethyl)phenyl; R1 = Me; n = 1 (B)), act in a competitive manner when they inhibit AChE or BChE. Mol. docking and dynamic simulation revealed that the synthesized compounds bind to the target by simultaneously interacting with the catalytic active site (CAS) and the peripheral anionic site (PAS) of both AChE and BChE. The U-shaped confirmation was preferred when (B) bound to BChE, which was different from the linear conformation of (A) bound to AChE. Cell-based assays have confirmed the moderate neuroprotective effects of compounds (A) and (B) against H2O2-induced oxidative damage towards PC12 cells. Moreover, the hepatotoxicity of (B) was lower than that of tacrine, indicating its potential safety as an anti-Alzheimer’s agent. In summary, a new chemotype of multifunctional hybrid, which may be further modified to develop new anti-Alzheimer’s agents was reported. The experimental part of the paper was very detailed, including the reaction process of 1-(Bromomethyl)-4-chlorobenzene(cas: 622-95-7Application In Synthesis of 1-(Bromomethyl)-4-chlorobenzene)
1-(Bromomethyl)-4-chlorobenzene(cas: 622-95-7) undergoes carbonylation in the presence of dimer of chloro(1,5-cyclooctadiene)rhodium(I) to yield the corresponding phenylacetic acid.Application In Synthesis of 1-(Bromomethyl)-4-chlorobenzene It can be synthesized by reacting 4-chlorobenzyl alcohol with bromodimethylsulfonium bromide (BDMS) It can also be synthesized by refluxing a mixture of 4-chlorobenzaldehyde, chlorotrimethylsilane, 1,1,3,3-tetramethyldisiloxane and lithium bromide.
Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics